Early View e14206
ORIGINAL ARTICLE

Prognostic Impact of Synchronous and Metachronous Second Primary Cancers in Laryngeal Cancer Patients Treated With Radiotherapy: Variable With Time-Varying Effects and Cox Proportional Hazard Analyses

Akikazu Kobori

Corresponding Author

Akikazu Kobori

Department of Radiology, Gifu University Hospital, Gifu City, Gifu, Japan

Search for more papers by this author
Chiyoko Makita

Chiyoko Makita

Department of Radiology, Gifu University Hospital, Gifu City, Gifu, Japan

Search for more papers by this author
Osamu Tanaka

Osamu Tanaka

Department of Radiation Oncology, Asahi University Hospital, Gifu City, Gifu, Japan

Search for more papers by this author
Sunaho Okada

Sunaho Okada

Department of Radiation Oncology, Gifu Prefectural General Medical Center, Gifu City, Gifu, Japan

Search for more papers by this author
Yuichi Kajiura

Yuichi Kajiura

Department of Radiation Oncology, Gifu Prefectural General Medical Center, Gifu City, Gifu, Japan

Search for more papers by this author
Nansei Yamada

Nansei Yamada

Department of Otorhinolaryngology, Gifu Prefectural General Medical Center, Gifu City, Gifu, Japan

Search for more papers by this author
Masayuki Matsuo

Masayuki Matsuo

Department of Radiology, Gifu University Hospital, Gifu City, Gifu, Japan

Search for more papers by this author
First published: 22 June 2025

Funding: The authors received no specific funding for this work.

ABSTRACT

Aims

Patients with laryngeal and other head and neck cancers face a high risk of developing second primary cancers. This retrospective cohort study evaluated the prognostic value of second primary cancers in laryngeal cancer patients treated with radiotherapy.

Methods

We retrospectively investigated patients with laryngeal cancer who underwent radiotherapy, and evaluated the incidence and relative risk of synchronous and metachronous second primary cancers in a single-institution cohort.

Results

Between January 2007 and December 2021, 138 patients with laryngeal cancer were analyzed. The median follow-up period was 5.2 years. The 5-year overall survival rate was 82.4% and the progression-free survival rate was 71.9%. Synchronous and metachronous second primary cancers were observed in 15 (10.9%) and 38 (27.5%) patients, respectively, during the follow-up period. The cumulative incidence of metachronous second primary cancers was 23.3% at 5 years. Moreover, deaths from laryngeal cancer, other cancers, and noncancer illnesses accounted for 3.6% (5 patients), 12.3% (17 patients), and 10.9% (17 patients), respectively, with most deaths from causes other than laryngeal cancer occurring after the first 5 years. Synchronous second primary cancer was a significant prognostic factor of poor outcomes (hazard ratio, 4.42; 95% confidence interval, 1.93–10.13) on time-independent multivariate analysis, and metachronous second primary cancer was a significant prognostic factor of poor outcomes (hazard ratio, 4.55; 95% confidence interval, 2.09–9.91) in the time-dependent Cox proportional hazards model.

Conclusion

Synchronous and metachronous second primary cancers are significant prognostic factors for patients with laryngeal cancer treated with radiotherapy.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.